Cargando…
Tonic suppression of PCAT29 by the IL-6 signaling pathway in prostate cancer: Reversal by resveratrol
Prostate cancer (PCa) is the second leading cause of cancer deaths in men. A better understanding of the molecular basis of prostate cancer proliferation and metastasis should enable development of more effective treatments. In this study we focused on the lncRNA, prostate cancer associated transcri...
Autores principales: | Al Aameri, Raheem F. H., Sheth, Sandeep, Alanisi, Entkhab M. A., Borse, Vikrant, Mukherjea, Debashree, Rybak, Leonard P., Ramkumar, Vickram |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5415196/ https://www.ncbi.nlm.nih.gov/pubmed/28467474 http://dx.doi.org/10.1371/journal.pone.0177198 |
Ejemplares similares
-
Regulator of G protein signaling 17 represents a novel target for treating cisplatin induced hearing loss
por: Dhukhwa, Asmita, et al.
Publicado: (2021) -
Capsaicin Protects Against Cisplatin Ototoxicity by Changing the STAT3/STAT1 Ratio and Activating Cannabinoid (CB2) Receptors in the Cochlea
por: Bhatta, Puspanjali, et al.
Publicado: (2019) -
Targeting CXCL1 chemokine signaling for treating cisplatin ototoxicity
por: Al Aameri, Raheem F. H., et al.
Publicado: (2023) -
The Endocannabinoid/Cannabinoid Receptor 2 System Protects Against Cisplatin-Induced Hearing Loss
por: Ghosh, Sumana, et al.
Publicado: (2018) -
Oral Administration of Caffeine Exacerbates Cisplatin-Induced Hearing Loss
por: Sheth, Sandeep, et al.
Publicado: (2019)